These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21509909)

  • 1. Efficacy of scheduled infliximab maintenance therapy on systemic amyloidosis associated with crohn's disease.
    Iizuka M; Sagara S; Etou T
    Inflamm Bowel Dis; 2011 Jul; 17(7):E67-8. PubMed ID: 21509909
    [No Abstract]   [Full Text] [Related]  

  • 2. Infiximab for treatment of systemic amyloidosis associated with Crohn's disease.
    Said Y; Debbeche R; Hamzaoui L; Lounissi M; Trabelsi S; Bouzaidi S; Salem M; Abdelmoula L; Najjar T
    J Crohns Colitis; 2011 Apr; 5(2):171-2. PubMed ID: 21453891
    [No Abstract]   [Full Text] [Related]  

  • 3. Secondary amyloidosis in a patient with long duration Crohn's disease treated with infliximab.
    Fidalgo C; Calado J; Cravo M
    BioDrugs; 2010 Dec; 24 Suppl 1():15-7. PubMed ID: 21175229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of infliximab induction therapy on secondary systemic amyloidosis associated with Crohn's disease: case report and review of the literature.
    Pukitis A; Zake T; Groma V; Ostrovskis E; Skuja S; Pokrotnieks J
    J Gastrointestin Liver Dis; 2013 Sep; 22(3):333-6. PubMed ID: 24078992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful use of maintenance infliximab for nephropathy in a patient with secondary amyloidosis complicating Crohn's disease.
    Tada Y; Ishihara S; Ito T; Matsui K; Sonoyama H; Oka A; Kusunoki R; Fukuba N; Mishima Y; Oshima N; Moriyama I; Yuki T; Kawashima K; Sato S; Adachi K; Ikeuchi H; Kinoshita Y
    Intern Med; 2013; 52(17):1899-902. PubMed ID: 23994979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic amyloidosis with Crohn's disease treated with infliximab.
    Park YK; Han DS; Eun CS
    Inflamm Bowel Dis; 2008 Mar; 14(3):431-2. PubMed ID: 17932971
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-TNF-α therapy for renal amyloid as a complication of Crohn's disease.
    Blackmur JP; Chapman FA; Bellamy CO; Save V; Plevris JN; Shand AG; Whitworth C; Dhaun N
    QJM; 2014 Jan; 107(1):57-9. PubMed ID: 23681221
    [No Abstract]   [Full Text] [Related]  

  • 8. [Infliximab and amyloidosis secondary to inflammatory bowel diseases].
    Callejas Rubio JL; Ortego Centeno N; Cárdeña Pérez C; Navas-Parejo A
    Med Clin (Barc); 2005 May; 124(19):757-8; author reply 758. PubMed ID: 15919041
    [No Abstract]   [Full Text] [Related]  

  • 9. Infliximab in the treatment of amyloidosis secondary to Crohn's disease.
    Cabezuelo JB; Egea JP; Ramos F; Torrella E; Muray S; Alcázar C
    Nefrologia; 2012 May; 32(3):385-8. PubMed ID: 22592423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Esophageal ulcer of Crohn's disease: disappearance in 1 week with infliximab.
    Chiba M; Sugawara T; Tsuda H; Abe T; Tokairin T; Kashima Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1121-2. PubMed ID: 18942761
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyloidosis secondary to hidradenitis suppurativa. Exceptional response to infliximab.
    Montes-Romero JA; Callejas-Rubio JL; Sánchez-Cano D; González-Martínez FJ; Navas-Parejo A; Ortego-Centeno N
    Eur J Intern Med; 2008 Oct; 19(6):e32-3. PubMed ID: 18848164
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful Pregnancies After Regression of AA Amyloidosis by Anti-inflammatory Therapy in Chronic Active Crohn's Disease.
    Blesl A; Rainer F; Pollheimer M; Kump P; Durchschein F; Wenzl H; Eller K; Krisper P; Petritsch W; Högenauer C
    Dig Dis Sci; 2020 Sep; 65(9):2730-2734. PubMed ID: 31865490
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of trough serum infliximab to clinical outcome after scheduled maintenance treatment for Crohn's disease.
    Maser EA; Villela R; Silverberg MS; Greenberg GR
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1248-54. PubMed ID: 16931170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aseptic osteomyelitis responding to TNFalpha antagonist therapy in a patient with Crohn's disease.
    Bret J; Lemaire O; Prat C; Zabraniecki L; Fournie B
    Joint Bone Spine; 2008 Jul; 75(4):489-91. PubMed ID: 18550412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal amyloidosis after a short period since diagnosis of ileocolonic Crohn's disease.
    Karaahmet F; Akinci H; Hamamci M; Bahceci M; Coban S; Yuksel I
    J Gastrointestin Liver Dis; 2013 Dec; 22(4):473-4. PubMed ID: 24369336
    [No Abstract]   [Full Text] [Related]  

  • 16. Anti-TNFalpha therapy in a rare case of Crohn's disease: still a panacea.
    Verburg R; Zelissen P; Rothova A; Siersema PD; Oldenburg B
    Inflamm Bowel Dis; 2008 Oct; 14(10):1457-60. PubMed ID: 18383178
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-TNF-alpha for treatment of amyloidosis associated with Crohn's disease.
    Fernández-Nebro A; Ureña I; Irigoyen MV; García-Vicuña R
    Gut; 2006 Nov; 55(11):1666-7; author reply 1667. PubMed ID: 17047117
    [No Abstract]   [Full Text] [Related]  

  • 18. Metastatic vulval Crohn's disease and infliximab: a case report.
    Tritton SM; Whyte L; Fischer G
    J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hemorrhagic Crohn's disease controlled with infliximab.
    Meyer MM; Levine EJ
    Inflamm Bowel Dis; 2009 Oct; 15(10):1456-7. PubMed ID: 19107774
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal pain due to cholecystitis as first sign of septic salmonellosis in a patient with Crohn's disease on infliximab.
    Kukiolka T; Neurath MF; Mudter J
    Inflamm Bowel Dis; 2011 Jun; 17(6):E48-9. PubMed ID: 21472825
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.